Sponsor pipeline

Aulos Bioscience, Inc. clinical trial pipeline

Get alerts when Aulos Bioscience, Inc.'s trials change

1 active trials 1 recruiting 3 disease areas 2 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

What changed in the last 30 days

2026-07-31
critical
Primary completion pushed: 2026-06-12 → 2027-02-28
Completion pushed: 2026-06-12 → 2027-02-28
NCT05267626 Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in… · Phase 1/2

Active trials by phase

Phase 1/2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1/2
NCT05267626 Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in… Advanced Solid Tumor Recruiting 2026-07-30

Disease areas by active trials

Get alerts when Aulos Bioscience, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free